Financials
- Market Capitalization 3.48 B
- Employee 562
- Founded 2012
- CEO Carl Hansen
- Website www.abcellera.com
- Headquarter British Columbia, Canada
- FIGI BBG00LLW2MF2
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-6.98
Fiyat/satışlar oranı
13.6
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1574 | IOVA Iovance Biotherapeutics, Inc. - Common Stock | 8.03 USD | -2.78% | -3.14% | +69.77% | +260.09% | 3.64 B USD | ||
| 1604 | VCYT Veracyte, Inc. - Common Stock | 43.34 USD | -4.22% | +2.43% | -22.65% | +17.45% | 3.48 B USD | ||
| 1633 | QURE uniQure N.V. - Ordinary Shares | 48.71 USD | -1.72% | +0.70% | +27.61% | +199.94% | 3.38 B USD | ||
| 1639 | GPCR Structure Therapeutics Inc - American Depositary Shares | 47.47 USD | -3.56% | -3.30% | +0.79% | +77.52% | 3.39 B USD |